Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 5 Stepping Stones to the Future State of Rare Disease Clinical Development By Leslie Wetherell November 14, 2023 Clinical ResearchPhase 1 - Phase 4 Getting It Right from the Start: 10 Essentials for Designing Biomarker-Guided Oncology Clinical Studies By Ashley Herrick October 20, 2023 Clinical ResearchPhase 1 - Phase 4 Navigating the FDA’s Draft Guidance on Psychedelic Drug Development By Adam Simmons October 18, 2023 Clinical ResearchPhase 1 - Phase 4 Operationalizing Biomarker-Guided Oncology Trials: Planning for Success By Ashley Herrick October 17, 2023 Clinical ResearchPhase 1 - Phase 4 Leveraging Technology and Expert Clinician Review to Enhance Risk Detection in Neuroscience Studies By Andreas Schreiner October 16, 2023 Clinical ResearchPhase 1 - Phase 4 What Patient Population is Participating in Your Early-Phase Gene Therapy Trials? These Factors Could Influence Your Strategy By Kenneth Ndugga-Kabuye September 6, 2023 Previous 1 …3 4 5 6 7 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today